Arising from the epithelial lining of the urinary bladder, the bladder cancer characteristically causes blood in the urine with frequent painful urination. Bladder cancer is a highly prevalent disease and is associated with substantial morbidity, mortality, and cost. However, new advances in therapeutic outcomes for bladder cancer can improve patient quality and quantity of life. In this exclusive Docplexus KOL interview, Dr.
Hemant Tongaonkar talks about “ Therapeutic Outcomes For Muscle Invasive Bladder Cancer.” Dr. Hemant Tongaonkar is a Consultant Surgical Oncologist at PD Hinduja Hospital and Medical Research Centre, Mumbai with a clinical experience of over 25 years.
